UC BERKELEY AUTHORS: Maya L Petersen
DATE OF PUBLICATION: February 2021
REGION: East Africa
DOI: https://doi.org/10.1371/journal.pmed.1003492
SUMMARY/ABSTRACT: Oral pre-exposure prophylaxis (PrEP) is highly effective for HIV prevention, but data are limited on HIV incidence among PrEP users in generalized epidemic settings, particularly outside of selected risk groups. We performed a population-based PrEP study in rural Kenya and Uganda and sought to evaluate both changes in HIV incidence and clinical and virologic outcomes following seroconversion on PrEP.
ACCESS: https://pubmed.ncbi.nlm.nih.gov/33561143/